Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2025-12-24 @ 2:17 PM
NCT ID:
NCT00201695
Eligibility Criteria:
Inclusion Criteria:
* Must have Multiple Myeloma
* No prior chemotherapy, thalidomide, or corticosteroids treatments for Multiple Myeloma
* ECOG performance status must be 0-2
Exclusion Criteria:
* Resting left ventricular cardiac ejection fraction ≥50% by echo or MUGA scan.
* QT interval ≥480 msec on baseline ECG.
* No history of cardiac disease.
* Pregnant or breast-feeding.
* No history of hypersensitivity reactions attributed to a conventional formulation of doxorubicin HCL or the components of Doxil.
* History of prior or concurrent malignancy or myelodysplasia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00201695
Study Brief:
Protocol Section:
NCT00201695